Healthcare

This Genetic Technology TechVision Opportunity Engine (TOE) depicts gene therapy innovations for cancer research. The corresponding clinical trials scenario for lysosomal storage diseases is also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities ...

The latest issue of Medical Imaging and Diagnostics TOE profiles innovations in the medical imaging and diagnostics industry. Some of the profiles covered include development of colored X-rays, artificial iris, next generation cancer imaging system, 3D nano-imaging, low-dose CT scan, and novel X-ray instrumentation. Medical Imaging and Diagnostics...

The latest edition of Medical Device TOE profiles innovations in orthobiologics, artificial intelligence in medical diagnosis, non-invasive health monitoring, and cybersecurity for medical devices. Innovations in focus include a supercomputer to understand the functioning of the brain, ECG patch for atrial fibrillation diagnosis, through-the-skin...

The medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal le...

Healthcare is an information intensive industry and healthcare data is increasingly being seen as an asset which needs to be invested in for organizations to be able to reap returns. Healthcare providers have started developing data management strategies that revolve around current and future data sources, users and applications. There is a need fo...

The Genetic Technology TechVision Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across precision medicine. Precision medicine strategies targeting mRNA splicing, novel therapies for inherited disorders, microbiome-based therapies for inflammatory diseases, and gene editing technologies fueling personalized ...